The Cut: Can my acne products cause cancer?
The University of Cincinnati's Kelly Dobos spoke with The Cut about the risk of benzene exposure in common acne products.
Recently, an independent laboratory filed a petition with the Food and Drug Administration requesting the recall of products that contain an over-the-counter acne-treating drug called benzoyl peroxide due to elevated levels of the carcinogen benzene.
“Unless someone is keeping their acne treatment in a car during the hottest days of summer, it’s incredibly unlikely your product will experience that kind of condition" of increased benzene exposure, Dobos, a cosmetic chemist and adjunct instructor in UC's Cosmetic Science Program in the James L. Winkle College of Pharmacy, told The Cut.
Dobos noted most people are exposed to at least some level of benzene every day, regardless of the acne products they use. People can experience elevated levels when cooking over a gas flame, putting fuel in your car or sitting next to a person who is vaping or smoking.
“According to information from the World Health Organization, outdoor air has a background benzene level ranging from 0.31 parts per billion in rural areas to 1.5 to 2.3 parts per billion in suburbs and cities," she said.
Featured photo at top of a woman washing her face. Photo/Extreme Photographer/iStock.
Related Stories
UC launches Bearcats Affordability Grant
January 7, 2026
The University of Cincinnati is making college more attainable for students across Ohio with the creation of the Bearcats Affordability Grant. The new grant will provide a pathway to tuition-free college for students of families who make less than $75,000 per year. Beginning in fall 2026, the Bearcats Affordability Grant will cover the remaining cost of tuition for Ohio residents who are Pell eligible.
BearcatGPT AI platform now available to all UC faculty and staff
December 9, 2025
University of Cincinnati Digital Technology Solutions is excited to announce that BearcatGPT, the university’s private, secure AI platform, is now available to all UC faculty and staff.
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.